These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

576 related items for PubMed ID: 29048733

  • 1. Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute.
    Yang J, Nolte FS, Chajewski OS, Lindsey KG, Houser PM, Pellicier J, Wang Q, Ehsani L.
    Diagn Cytopathol; 2018 Jan; 46(1):22-27. PubMed ID: 29048733
    [Abstract] [Full Text] [Related]

  • 2. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
    Demarco M, Lorey TS, Fetterman B, Cheung LC, Guido RS, Wentzensen N, Kinney WK, Poitras NE, Befano B, Castle PE, Schiffman M.
    J Low Genit Tract Dis; 2017 Oct; 21(4):261-267. PubMed ID: 28953116
    [Abstract] [Full Text] [Related]

  • 3. [Application of high-risk human papillomavirus testing in women with abnormal cytology].
    Ou H, Bian ML, Zhang XY, Chen QY, Li M, Chen Y, Liu J.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):608-11. PubMed ID: 18051714
    [Abstract] [Full Text] [Related]

  • 4. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
    Gustinucci D, Passamonti B, Cesarini E, Butera D, Palmieri EA, Bulletti S, Carlani A, Staiano M, D'Amico MR, D'Angelo V, Di Dato E, Martinelli N, Malaspina M, Spita N, Tintori B, Fulciniti F.
    Acta Cytol; 2012 Oct; 56(5):506-14. PubMed ID: 23075891
    [Abstract] [Full Text] [Related]

  • 5. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
    Evans MF, Adamson CS, Papillo JL, St John TL, Leiman G, Cooper K.
    Cancer; 2006 Mar 01; 106(5):1054-64. PubMed ID: 16421920
    [Abstract] [Full Text] [Related]

  • 6. Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: Real-world data from regional cervical cancer screening program.
    Rosário A, Sousa A, Marinho-Dias J, Medeiros R, Lobo C, Leça L, Coimbra N, Tavares F, Baldaque I, Martins G, Monteiro P, Henrique R, Sousa H.
    J Med Virol; 2023 Jan 01; 95(1):e28414. PubMed ID: 36541747
    [Abstract] [Full Text] [Related]

  • 7. Punch biopsy guided by both colposcopy and HR-HPV status is more efficient for identification of immediate high-grade squamous intraepithelial lesion or worse among HPV-infected women with atypical squamous cells of undetermined significance.
    Ding Z, Li Y, Chen A, Song M, Zhang Y.
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec 01; 207():32-36. PubMed ID: 27816739
    [Abstract] [Full Text] [Related]

  • 8. Utility of P16 expression and Ki-67 proliferation index in ASCUS and ASC-H pap tests.
    Toll AD, Kelly D, Maleki Z.
    Diagn Cytopathol; 2014 Jul 01; 42(7):576-81. PubMed ID: 24288264
    [Abstract] [Full Text] [Related]

  • 9. Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.
    Shen-Gunther J, Wang CM, Poage GM, Lin CL, Perez L, Banks NA, Huang TH.
    Clin Epigenetics; 2016 Jul 01; 8(1):96. PubMed ID: 27651839
    [Abstract] [Full Text] [Related]

  • 10. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
    Wang JJ, Dong J, Deng ZX, Wang PF, Zhang XX, Du Y.
    Zhonghua Fu Chan Ke Za Zhi; 2019 May 25; 54(5):301-306. PubMed ID: 31154710
    [Abstract] [Full Text] [Related]

  • 11. P16/Ki-67 Dual Staining in Positive Human Papillomavirus DNA Testing for Predictive Diagnosis of Abnormal Cervical Lesions in Northeastern Thai Women.
    Aromseree S, Wongjumpa W, Ekalaksananan T, Temtanakitpaisan A, Kleebkaow P, Srisathaporn S, Tongchai P, Pientong C.
    Asian Pac J Cancer Prev; 2022 Oct 01; 23(10):3405-3411. PubMed ID: 36308365
    [Abstract] [Full Text] [Related]

  • 12. Implementation of the ThinPrep Imaging System in a tertiary military medical center.
    Duby JM, DiFurio MJ.
    Cancer; 2009 Aug 25; 117(4):264-70. PubMed ID: 19536887
    [Abstract] [Full Text] [Related]

  • 13. Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: diagnostic performance, human papillomavirus testing, and follow-up results.
    Srodon M, Parry Dilworth H, Ronnett BM.
    Cancer; 2006 Feb 25; 108(1):32-8. PubMed ID: 16136595
    [Abstract] [Full Text] [Related]

  • 14. Risk detection for high-grade cervical disease using Onclarity HPV extended genotyping in women, ≥21 years of age, with ASC-US or LSIL cytology.
    Wright TC, Stoler MH, Parvu V, Yanson K, Cooper C, Andrews J.
    Gynecol Oncol; 2019 Aug 25; 154(2):360-367. PubMed ID: 31160073
    [Abstract] [Full Text] [Related]

  • 15. Anal-rectal cytology: correlation with human papillomavirus status and biopsy diagnoses in a population of HIV-positive patients.
    Bean SM, Chhieng DC, Roberson J, Raper JL, Broker TR, Hoesley CJ, Eltoum IA, Jin G.
    J Low Genit Tract Dis; 2010 Apr 25; 14(2):90-6. PubMed ID: 20354415
    [Abstract] [Full Text] [Related]

  • 16. Population-based e-records to evaluate HPV triage of screen-detected atypical squamous cervical lesions in Catalonia, Spain, 2010-15.
    de Sanjosé S, Rodríguez-Salés V, Bosch XF, Ibañez R, Bruni L.
    PLoS One; 2018 Apr 25; 13(11):e0207812. PubMed ID: 30475876
    [Abstract] [Full Text] [Related]

  • 17. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
    Nakamura Y, Matsumoto K, Satoh T, Nishide K, Nozue A, Shimabukuro K, Endo S, Nagai K, Oki A, Ochi H, Morishita Y, Noguchi M, Yoshikawa H.
    Int J Clin Oncol; 2015 Oct 25; 20(5):974-81. PubMed ID: 25652908
    [Abstract] [Full Text] [Related]

  • 18. HPV infection and p16 promoter methylation as predictors of ASC-US/LSIL progression.
    Lee H, Lee EJ.
    Cancer Cytopathol; 2016 Jan 25; 124(1):58-65. PubMed ID: 26335500
    [Abstract] [Full Text] [Related]

  • 19.
    Ndifon CO, Al-Eyd G.
    ; 2024 01 25. PubMed ID: 32491671
    [Abstract] [Full Text] [Related]

  • 20. Atypical Squamous Cells in Liquid-Based Cervical Cytology: Microbiology, Inflammatory Infiltrate, and Human Papillomavirus-DNA Testing.
    Gomes de Oliveira G, Eleutério RMN, Silveira Gonçalves AK, Giraldo PC, Eleutério J.
    Acta Cytol; 2018 01 25; 62(1):28-33. PubMed ID: 29130974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.